Patrick Kee, MD
Cardiovascular Disease · Humble, TXNPI 1881600815
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,735 of the $14,146 with a category attached, or 75.9%. Amgen accounts for 83.7% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $8,807 and has fallen 52.3% since, to $4,198 in 2025.
Across 70 payments — averaging $202.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$12K
- Cvrx, Inc.$356
- E.r. Squibb & Sons, L.L.C.$268
- Kestra Medical Technology Services, Inc.$222
- Heartflow, Inc.$205
- W. L. Gore & Associates, Inc.$192
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$10,73576%
- Travel & lodging$50%
- Food & beverage$3,40624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 22 | $11,843 |
| Cvrx, Inc. | 3 | $356 |
| E.r. Squibb & Sons, L.L.C. | 8 | $268 |
| Kestra Medical Technology Services, Inc. | 3 | $222 |
| Heartflow, Inc. | 3 | $205 |
| W. L. Gore & Associates, Inc. | 1 | $192 |
| Lantheus Medical Imaging, Inc. | 5 | $167 |
| Regeneron Healthcare Solutions, Inc. | 3 | $160 |
| Novo Nordisk | 3 | $105 |
| Canon Medical Systems USA, Inc. | 3 | $99 |
| Abbott | 1 | $92 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $81 |
| Medtronic | 3 | $71 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $49 |
| Boston Scientific | 1 | $44 |
| Mindray DS USA, Inc. | 2 | $43 |
| Novartis | 1 | $34 |
| Edwards Lifesciences | 1 | $32 |
| Regeneron | 1 | $27 |
| Angiodynamics, Inc. | 1 | $16 |
| GE HealthCare | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$11,321
- Barostim Neo System$329
- GORE CARDIOFORM Septal Occluder$192
- EVKEEZA$121
- FFRct$115
- Assure WCD$109
How this compares
$14,146 in reported general payments places this provider in the 80th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $30,392 |
| Dofetilide | 14 | $2,787 |
| Metoprolol Succinate | 44 | $620 |
| Chlorthalidone | 22 | $537 |
| Atorvastatin Calcium | 46 | $522 |
| Rosuvastatin Calcium | 28 | $315 |
| Ezetimibe | 23 | $302 |
| Carvedilol | 26 | $278 |
| Losartan Potassium | 21 | $270 |
| Spironolactone | 18 | $223 |
| Amlodipine Besylate | 23 | $158 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 18 | $154 |
| Lisinopril | 15 | $134 |
| Nifedipine ErNifedipine | 11 | $103 |
| Furosemide | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Humble
- Naddi MarahHumble$133K
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
- Robert SalazarKingwood$478K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.